normal human immunoglobulin

It is used for patients (adults and children) who have antibody levels that are too low to fight infections. It is used to treat those born with a reduced ability to produce antibodies or those who have developed an antibody deficiency due to specific diseases or treatments.

Form: solution for injection

ATC: J06BA01

Manufacturer: OCTAPHARMA ITALY S.P.A.

It is used for patients with a weakened immune system who do not have a sufficient number of antibodies in the blood. It is prescribed for those with congenital antibody deficiency, for patients with chronic lymphocytic leukemia or multiple myeloma presenting with recurrent infections, and for those with reduced antibody production following a bone marrow cell transplant.

Form: solution for injection

ATC: J06BA01

Manufacturer: BAXALTA INNOVATIONS GMBH

It is used to treat patients with antibody deficiency (both congenital and secondary) to prevent infections, and to treat certain inflammatory disorders such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, multifocal motor neuropathy, and CIDP.

Form: solution for infusion

ATC: J06BA02

Manufacturer: TAKEDA MANUFACTURING AUSTRIA AG

It is used for the treatment of adults, children, and adolescents with insufficient antibody levels (such as in Primary or Secondary Immunodeficiency Syndrome) or for protection against measles. It is also indicated for several autoimmune conditions, including Primary Immune Thrombocytopenia, Guillain-Barré Syndrome, Kawasaki Disease, CIDP, and multifocal motor neuropathy.

Form: solution for infusion

ATC: J06BA02

Manufacturer: INSTITUTO GRIFOLS S.A.

It is used to treat various conditions in which the immune system does not function correctly. It serves as antibody replacement therapy in patients with low antibody levels (such as in cases of Primary Immunodeficiency Syndrome, AIDS, chronic lymphocytic leukemia, multiple myeloma, or after stem cell transplantation) and as immune system regulation therapy in cases of Primary Immune Thrombocytopenia, Guillain-Barré Syndrome, and Kawasaki Disease.

Form: solution for infusion, powder and solvent for preparation

ATC: J06BA02

Manufacturer: BAXALTA INNOVATIONS GMBH

It is used as replacement therapy for children, adolescents, and adults with antibody deficiencies (both congenital and acquired) and to protect those exposed to measles. It can also be used for certain autoimmune diseases such as immune thrombocytopenia, Kawasaki disease, Guillain-Barré syndrome, CIDP, multifocal motor neuropathy, and dermatomyositis.

Form: solution for infusion

ATC: J06BA02

Manufacturer: OCTAPHARMA ITALY S.P.A.

It is used to treat various conditions in which the immune system does not function correctly. It is indicated for replacement therapy in patients with antibody deficiency (such as in primary or acquired immunodeficiency syndromes), for protection against measles in at-risk individuals, and for certain autoimmune diseases such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, CIDP, MMN, and for severe acute phases of myasthenia gravis.

Form: solution for infusion

ATC: J06BA02

Manufacturer: GRIFOLS DEUTSCHLAND GMBH

It is used as replacement therapy for children, adolescents, and adults with antibody deficiencies (both congenital and acquired) and for protection against diseases such as measles in susceptible individuals. It is also used to treat certain autoimmune disorders, including immune thrombocytopenia (ITP), Kawasaki disease, Guillain-Barré syndrome, CIDP, and multifocal motor neuropathy (MMN).

Form: solution for infusion

ATC: J06BA02

Manufacturer: OCTAPHARMA ITALY S.P.A.

Hizentra is used to increase immunoglobulin levels in the blood in adults and children with immunodeficiencies (primary or secondary) and for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

Form: solution for injection

ATC: J06BA01

Manufacturer: CSL BEHRING GMBH

It is used as replacement therapy for adults and children with a weak immune system that does not produce enough antibodies, and as immunomodulatory therapy for patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Form: solution for infusion

ATC: J06BA01

Manufacturer: BAXALTA INNOVATIONS GMBH

It is used for the treatment of adults, children, and adolescents who do not have enough antibodies (replacement therapy for primary or secondary immunodeficiencies) or to treat certain inflammatory diseases such as Primary Immune Thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, CIDP, and Multifocal Motor Neuropathy.

Form: solution for infusion

ATC: J06BA02

Manufacturer: KEDRION S.P.A.

It is used in adults, children, and adolescents for replacement therapy in case of antibody deficiency (both congenital and acquired) and for the treatment of various inflammatory disorders, such as Guillain-Barré Syndrome, Kawasaki Disease, primary immune thrombocytopenia, and certain neuropathies.

Form: solution for infusion

ATC: J06BA02

Manufacturer: BIOTEST PHARMA GMBH

This medicinal product contains human antibodies and is used for two main purposes: as replacement therapy for those who do not have enough antibodies (due to congenital or acquired problems) and for the treatment of certain inflammatory diseases, such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, and certain neuropathies.

Form: solution for infusion

ATC: J06BA02

Manufacturer: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

It is used to restore antibody levels to normal in the blood of adult patients with primary immunodeficiencies. It is also indicated for the treatment of certain blood cancers (such as chronic lymphocytic leukemia and multiple myeloma) that cause low antibody levels and recurrent bacterial infections, or for those who have undergone a hematopoietic stem cell transplant.

Form: solution for infusion

ATC: J06BA01

Manufacturer: KEDRION S.P.A.

This medicine is used for two main purposes: as replacement therapy for patients who do not have enough antibodies in their blood (to prevent recurrent infections) and for the treatment of certain inflammatory or autoimmune diseases, such as Guillain-Barré syndrome, Kawasaki disease, or primary immune thrombocytopenia.

Form: solution for infusion

ATC: J06BA02

Manufacturer: TAKEDA MANUFACTURING AUSTRIA AG

It is used to restore normal antibody levels in the blood of adults with primary immunodeficiencies, to treat blood cancers that cause low antibody levels and recurrent bacterial infections, in patients with chronic lymphocytic leukemia or multiple myeloma, and in patients who are undergoing or have undergone hematopoietic stem cell transplantation.

Form: solution for infusion

ATC: J06BA01

Manufacturer: KEDRION S.P.A.

It is used as replacement therapy for children, adolescents, and adults with antibody deficiencies (both congenital and acquired) or for those at risk of measles exposure. It can also be used to treat certain autoimmune diseases such as immune thrombocytopenia, Kawasaki disease, Guillain-Barré syndrome, CIDP, and multifocal motor neuropathy.

Form: solution for infusion

ATC: J06BA02

Manufacturer: OCTAPHARMA ITALY S.P.A.

Octanorm contains antibodies that protect the body and increase resistance to infections. It is used as replacement therapy for adults, children, and adolescents with reduced capacity to produce immunoglobulins, and for patients with chronic lymphocytic leukemia, multiple myeloma, or antibody deficiency before and after a hematopoietic stem cell transplant.

Form: solution for injection

ATC: J06BA01

Manufacturer: OCTAPHARMA ITALY S.P.A.

It is used to treat various conditions in which the immune system does not function correctly. Specifically, it serves as replacement therapy for those with antibody deficiency and for the treatment of certain autoimmune diseases, such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, CIDP, and multifocal motor neuropathy.

Form: solution for infusion

ATC: J06BA02

Manufacturer: INSTITUTO GRIFOLS S.A.

It is used to increase immunoglobulin levels in the blood in patients with immunodeficiencies (primary or acquired) and to treat various inflammatory diseases, such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, and certain neuropathies.

Form: solution for infusion

ATC: J06BA02

Manufacturer: CSL BEHRING GMBH

It is used to increase antibody (immunoglobulin) levels in the blood in adults, children, and adolescents suffering from immunodeficiency, such as in primary immunodeficiency syndromes, in hypogammaglobulinemia associated with chronic lymphocytic leukemia, multiple myeloma, or after a stem cell transplant.

Form: solution for injection

ATC: J06BA01

Manufacturer: INSTITUTO GRIFOLS S.A.